IDEAco

IDEAco is a biotechnology company focused on the development of innovative therapeutic solutions for complex medical challenges, particularly in the fields of infectious diseases and oncology. The company leverages advanced research and development capabilities to identify and advance promising drug candidates through the early stages of the clinical pipeline. IDEAco aims to address significant unmet medical needs by utilizing a combination of small molecule and biologic modalities. With a commitment to scientific excellence, the company collaborates with various partners to accelerate the translation of its research into effective treatments. IDEAco is currently in the pre-clinical stage, working to validate its core technologies and therapeutic approaches.